Involvement of agouti-related protein, an endogenous antagonist of hypothalamic melanocortin receptor, in leptin action
Authors
Ebihara, K
Ogawa, Y
Katsuura, G
Numata, Y
Masuzaki, H
Satoh, N
Tamaki, M
Yoshioka, T
Hayase, M
Matsuoka, N
Aizawa-Abe, M
Yoshimasa, Y
Nakao, K
Citation
K. Ebihara et al., Involvement of agouti-related protein, an endogenous antagonist of hypothalamic melanocortin receptor, in leptin action, DIABETES, 48(10), 1999, pp. 2028-2033
Categorie Soggetti
Endocrynology, Metabolism & Nutrition","Endocrinology, Nutrition & Metabolism
SICI code
0012-1797(199910)48:10<2028:IOAPAE>2.0.ZU;2-C
Abstract
To understand the role of agouti-related protein (AGRP), an endogenous anta
gonist of hypothalamic melanocortin receptor, in leptin action, we produced
a full-length recombinant AGRP and examined its effect on the satiety effe
ct of leptin. We also studied leptin's regulation of hypothalamic AGRP mRNA
expression. A single intracerebroventricular (ICV) injection of AGRP signi
ficantly increased cumulative food intake and body weight in a dose-depende
nt manner in rats. The leptin-induced inhibition of food intake and body we
ight was reversed by co-injection of AGRP in a dose-dependent manner. Hypot
halamic AGRP mRNA expression a-as upregulated in leptin-deficient ob/ob mic
e and leptin receptor-deficient db/db mice and downregulated in lethal yell
ow agouti mice (KKA(y) mice) with hyperleptinemia. A single ICV injection o
f leptin reversed the increased AGRP mRNA levels in ob/ob mice but not in d
b/db, mice. In control mice and KKA(y) mice, AGRP mRNA expression was upreg
ulated during fasting, when plasma. leptin concentrations were decreased. N
o significant increase in AGRP mRNA expression was noted during fasting in
control mice and KKA(y) mice treated with leptin. This study provides the f
irst direct evidence that AGRP is a negative regulator of leptin action, an
d leptin downregulates hypothalamic AGRP production. Because leptin is show
n to increase hypothalamic ol-melanocyte stimulating hormone (alpha-MSH) pr
oduction, our data suggest that its action via the hypothalamic melanocorti
n system is determined by the balance between the levels of its agonist and
antagonist, alpha-MSH and AGRP.